Constellation Investments’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.41M Buy
20,000
+300
+2% +$20K 0.26% 80
2015
Q4
$1.31M Buy
19,700
+300
+2% +$20K 0.25% 87
2015
Q3
$1.23M Buy
19,400
+1,100
+6% +$71.9K 0.25% 83
2015
Q2
$1.2M Buy
18,300
+200
+1% +$13.6K 0.23% 97
2015
Q1
$1.25M Buy
18,100
+700
+4% +$48.4K 0.24% 92
2014
Q4
$1.2M Buy
17,400
+700
+4% +$47.3K 0.24% 95
2014
Q3
$1.09M Buy
16,700
+100
+0.6% +$6.6K 0.24% 95
2014
Q2
$1.13M Buy
16,600
+200
+1% +$13.4K 0.26% 92
2014
Q1
$1.06M Buy
16,400
+300
+2% +$18.9K 0.26% 90
2013
Q4
$1.05M Buy
16,100
+1,100
+7% +$70.4K 0.27% 84
2013
Q3
$890K Buy
15,000
+900
+6% +$53.3K 0.27% 85
2013
Q2
$808K Buy
+14,100
New +$837K 0.28% 78

Other funds holding CL

Constellation Investments's CL Position: Q1 2016 in Review

Constellation Investments increased its Colgate-Palmolive (CL) stake by 1.5% in Q1 2016, buying an estimated $20K and bringing the position to 20,000 shares worth $1.41M. The position accounts for 0.26% of the portfolio, ranked #80.

Constellation Investments first reported a position in CL in Q2 2013 and has held it in 12 quarters since. 1,263 funds tracked by Wall St. Rank hold CL as of Q1 2016.

  • Constellation Investments held 20,000 shares of Colgate-Palmolive worth $1.41M as of Q1 2016.
  • Constellation Investments bought 300 Colgate-Palmolive shares in Q1 2016, an estimated $20K.
  • Colgate-Palmolive made up 0.26% of Constellation Investments's portfolio in Q1 2016, its #80 holding.
  • Constellation Investments first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 12 quarters since.
  • 1,263 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.